Abstract:We aimed to assess the impact of the COVID-19 pandemic on blood pressure (BP) control assessed by office and ambulatory blood pressure monitoring (ABPM) in patients with treated hypertension. Clinical and BP data were collected from 32 centres including Excellence Centres of the European Society of Hypertension. Two groups of patients were compared. Group1 (‘pandemic’) consisting of participants who have undergone two ABPM recordings (visits): visit-2 during the COVID-19 pandemic, and visit-1 performed 9 - 15 months prior to visit-2. Participants in Group2 (‘pre-pandemic’) had two repeated ABPMs, both performed before the pandemic within 9 - 15 months interval between visits. Overall, 3384 ABPMs were collected from 1692 patients (50.5% men). 759 patients constituted Group1 and 933 patients Group2. Study groups did not differ regarding sex, age, or body weight. The duration of hypertension and frequency of first-line antihypertensive drug use at visit-1 were also similar in both groups. Beta-blockers were the only class of drugs with a significant decrease between visits (difference between visit-2 and visit-1) in Group1. At visit-1, there were no differences in all BP phenotypes (office and ABPM values) or hypertension control rates (27% vs 26.6%; p = 0.62) between study groups. At visit-2 significantly higher office BP was observed in Group1 compared to Group2, with a mean difference of +2.09 mmHg (p = 0.028) and +1.39 mmHg (p = 0.026) for systolic (SBP) and diastolic (DBP) BP, respectively. Moreover, on visit-2, higher 24-hour daytime and nighttime SBP and DBP were observed in Group1 as compared to Group2. Of note, the prevalence of uncontrolled hypertension (when considering both office and ABPM) was also higher at visit-2 in Goup1 than in Group2 (25.8% vs 20.0%; p = 0.005). Both SBP and DBP, regardless of the measurement method, dropped between visit-1 to visit-2, but to a lesser extent in Group1. Thus, the magnitude of BP decrease between visits was smaller in Group1 (delta24SBP: -1.04 vs -3.2 mmHg; p < 0.001 and delta24DBP: -1.22 vs -1.93 mmHg; p = 0.038). The results of the study indicate a negative impact of the COVID-19 pandemic on BP control both in office and during ABPM.

Home Blood Pressure and Telemedicine: A Modern Approach for Managing Hypertension During and After COVID-19 Pandemic

Applications and outcomes of implementing telemedicine for hypertension management in COVID-19 pandemic: A systematic review

Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension

Rapid Evaluations of Telehealth Strategies to Address Hypertension: A Mixed-Methods Exploration at Two US Health Systems During the COVID-19 Pandemic

Telemedicine in the Management of Hypertension: Evolving Technological Platforms for Blood Pressure Telemonitoring

Evaluation of Pharmacist-Led Telemedicine Medication Management for Hypertension Established Patients During COVID-19 Pandemic: A Pilot Study.

Hypertension management and outcomes during the covid-19 pandemic: diagnosis, blood pressure telemonitoring use and mortality

Changes in Blood Pressure Outcomes Among Hypertensive Individuals During the COVID-19 Pandemic: A Time Series Analysis in Three US Healthcare Organizations

Home blood pressure telemonitoring in the 21st century

Telemedicine interventions for hypertension management in low- and middle-income countries: A scoping review

Medical Telemonitoring for the Management of Hypertension in Older Patients in Japan

Automatic transmission of home blood pressure data can be effective in managing hypertension: a systematic review and meta-analysis

COVID‐19 and Hypertension—evidence and Practical Management: Guidance from the HOPE Asia Network

THE IMPACT OF COVID-19 PANDEMIC ON BLOOD PRESSURE CONTROL IN PATIENTS WITH TREATED HYPERTENSION. RESULTS OF EUROPEAN SOCIETY OF HYPERTENSION STUDY (ESH ABPM COVID-19 STUDY)

COVID-19 and hypertension-evidence and practical management: Guidance from the HOPE Asia Network

Telemedicine: Benefits for Cardiovascular Patients in the COVID-19 Era

Managing cardiovascular risk factors with telemedicine in primary care: A systematic review and meta-analysis of patients with arterial hypertension and type 2 diabetes

Is remote blood pressure monitoring and management a better approach for patients with hypertension? A narrative review

Self-Measured Blood Pressure–Guided Pharmacotherapy: A Systematic Review and Meta-Analysis of US-Based Telemedicine Trials

Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension

The Importance of Telemedicine during COVID-19 Pandemic: A Focus on Diabetic Retinopathy